309 related articles for article (PubMed ID: 22388288)
1. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors.
Xie J; Ameres SL; Friedline R; Hung JH; Zhang Y; Xie Q; Zhong L; Su Q; He R; Li M; Li H; Mu X; Zhang H; Broderick JA; Kim JK; Weng Z; Flotte TR; Zamore PD; Gao G
Nat Methods; 2012 Mar; 9(4):403-9. PubMed ID: 22388288
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression.
Xie J; Xie Q; Zhang H; Ameres SL; Hung JH; Su Q; He R; Mu X; Seher Ahmed S; Park S; Kato H; Li C; Mueller C; Mello CC; Weng Z; Flotte TR; Zamore PD; Gao G
Mol Ther; 2011 Mar; 19(3):526-35. PubMed ID: 21179009
[TBL] [Abstract][Full Text] [Related]
3. Sustained miRNA-mediated knockdown of mutant AAT with simultaneous augmentation of wild-type AAT has minimal effect on global liver miRNA profiles.
Mueller C; Tang Q; Gruntman A; Blomenkamp K; Teckman J; Song L; Zamore PD; Flotte TR
Mol Ther; 2012 Mar; 20(3):590-600. PubMed ID: 22252449
[TBL] [Abstract][Full Text] [Related]
4. Generation of Efficient miRNA Inhibitors Using Tough Decoy Constructs.
Yoo J; Hajjar RJ; Jeong D
Methods Mol Biol; 2017; 1521():41-53. PubMed ID: 27910040
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus-mediated microRNA delivery and therapeutics.
Xie J; Burt DR; Gao G
Semin Liver Dis; 2015 Feb; 35(1):81-8. PubMed ID: 25632938
[TBL] [Abstract][Full Text] [Related]
6. Improved microRNA suppression by WPRE-linked tough decoy microRNA sponges.
Hollensen AK; Thomsen R; Bak RO; Petersen CC; Ermegaard ER; Aagaard L; Damgaard CK; Mikkelsen JG
RNA; 2017 Aug; 23(8):1247-1258. PubMed ID: 28487381
[TBL] [Abstract][Full Text] [Related]
7. Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction.
Muhuri M; Zhan W; Maeda Y; Li J; Lotun A; Chen J; Sylvia K; Dasgupta I; Arjomandnejad M; Nixon T; Keeler AM; Manokaran S; He R; Su Q; Tai PWL; Gao G
Front Immunol; 2021; 12():674242. PubMed ID: 33995418
[TBL] [Abstract][Full Text] [Related]
8. Rapid generation of microRNA sponges for microRNA inhibition.
Kluiver J; Gibcus JH; Hettinga C; Adema A; Richter MK; Halsema N; Slezak-Prochazka I; Ding Y; Kroesen BJ; van den Berg A
PLoS One; 2012; 7(1):e29275. PubMed ID: 22238599
[TBL] [Abstract][Full Text] [Related]
9. Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity.
Xiao Y; Muhuri M; Li S; Qin W; Xu G; Luo L; Li J; Letizia AJ; Wang SK; Chan YK; Wang C; Fuchs SP; Wang D; Su Q; Nahid MA; Church GM; Farzan M; Yang L; Wei Y; Desrosiers RC; Mueller C; Tai PW; Gao G
JCI Insight; 2019 May; 5(13):. PubMed ID: 31112525
[TBL] [Abstract][Full Text] [Related]
10. RNA accessibility impacts potency of Tough Decoy microRNA inhibitors.
Hooykaas MJG; Soppe JA; De Buhr HM; Kruse E; Wiertz EJHJ; Lebbink RJ
RNA Biol; 2018; 15(11):1410-1419. PubMed ID: 30339041
[TBL] [Abstract][Full Text] [Related]
11. Effective and Accurate Gene Silencing by a Recombinant AAV-Compatible MicroRNA Scaffold.
Xie J; Tai PWL; Brown A; Gong S; Zhu S; Wang Y; Li C; Colpan C; Su Q; He R; Ma H; Li J; Ye H; Ko J; Zamore PD; Gao G
Mol Ther; 2020 Feb; 28(2):422-430. PubMed ID: 31843447
[TBL] [Abstract][Full Text] [Related]
12. A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III.
He X; Wang Y; Fan X; Lei N; Tian Y; Zhang D; Pan W
J Hepatol; 2020 Mar; 72(3):519-527. PubMed ID: 31738999
[TBL] [Abstract][Full Text] [Related]
13. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy.
Ran G; Feng XL; Xie YL; Zheng QY; Guo PP; Yang M; Feng YL; Ling C; Zhu LQ; Zhong C
J Integr Med; 2021 Nov; 19(6):515-525. PubMed ID: 34538767
[TBL] [Abstract][Full Text] [Related]
14. Sustained expression of human factor VIII in mice using a parvovirus-based vector.
Chao H; Mao L; Bruce AT; Walsh CE
Blood; 2000 Mar; 95(5):1594-9. PubMed ID: 10688813
[TBL] [Abstract][Full Text] [Related]
15. miR-25 Tough Decoy Enhances Cardiac Function in Heart Failure.
Jeong D; Yoo J; Lee P; Kepreotis SV; Lee A; Wahlquist C; Brown BD; Kho C; Mercola M; Hajjar RJ
Mol Ther; 2018 Mar; 26(3):718-729. PubMed ID: 29273502
[TBL] [Abstract][Full Text] [Related]
16. Targeted correction of single-base-pair mutations with adeno-associated virus vectors under nonselective conditions.
Liu X; Yan Z; Luo M; Zak R; Li Z; Driskell RR; Huang Y; Tran N; Engelhardt JF
J Virol; 2004 Apr; 78(8):4165-75. PubMed ID: 15047832
[TBL] [Abstract][Full Text] [Related]
17. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo.
Nakai H; Yant SR; Storm TA; Fuess S; Meuse L; Kay MA
J Virol; 2001 Aug; 75(15):6969-76. PubMed ID: 11435577
[TBL] [Abstract][Full Text] [Related]
18. Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver.
Nakai H; Iwaki Y; Kay MA; Couto LB
J Virol; 1999 Jul; 73(7):5438-47. PubMed ID: 10364291
[TBL] [Abstract][Full Text] [Related]
19. rAAV6-mediated miR-29b delivery suppresses renal fibrosis.
Saito S; Ohno SI; Harada Y; Oikawa K; Fujita K; Mineo S; Gondo A; Kanno Y; Kuroda M
Clin Exp Nephrol; 2019 Dec; 23(12):1345-1356. PubMed ID: 31482255
[TBL] [Abstract][Full Text] [Related]
20. Recombinant adeno-associated virus 8-mediated inhibition of microRNA let-7a ameliorates sclerosing cholangitis in a clinically relevant mouse model.
Hua H; Zhao QQ; Kalagbor MN; Yu GZ; Liu M; Bian ZR; Zhang BB; Yu Q; Xu YH; Tang RX; Zheng KY; Yan C
World J Gastroenterol; 2024 Feb; 30(5):471-484. PubMed ID: 38414587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
